To ask His Majesty's Government how they plan to ensure the sustainability of the stroke rehabilitation innovations developed through the Stroke Quality Improvement in Rehabilitation (SQuIRe) projects to ensure that every stroke survivor has the best chan...
- Contact information
- Parliamentary career
- Experience
- Focus areas
- Voting record
- Spoken contributions
- Written questions
- Register of Interests
- APPG officer roles
- Staff
- Official portrait
Written questions
Review the written questions submitted by Baroness Wheeler.
To perform a more comprehensive search of written questions, visit the Parliamentary written questions and answers website.
To ask His Majesty's Government, further to the remarks by Lord Markham on 23 February where he stated that they will "write to all the NHS chief executives" (HL Deb col 1751), when that letter will be sent; and how they will monitor progress on services ...
To ask His Majesty's Government how NHS England and integrated care boards will hold trusts to account on performance in specialised services in line with latest service specifications.
To ask His Majesty's Government when they will publish their timeline for the update of service specifications in specialised services.
To ask His Majesty's Government what measures they are putting in place to ensure that unwarranted variation in access to specialised services does not increase due to the delegation of some of these services to the integrated care board level.
To ask His Majesty's Government how learnings from the two integrated care boards (ICBs) in South London that have taken on full commissioning responsibility for specialised services deemed suitable and ready will be applied to other ICBs ahead of full de...
To ask His Majesty's Government how many full-time equivalent NHS England staff were transferred from specialised commissioning to the monkeypox response workstreams.
To ask His Majesty's Government what assessment they have made of the finding by the Company Chemists’ Association that 720 pharmacies had closed permanently since 2015, 41 per cent of which were in England’s most deprived areas; and what steps they are t...
To ask His Majesty's Government what steps they are taking (1) to build and expand essential community pharmacy services, and (2) to prevent further closures of both large and small high street pharmacies.
To ask His Majesty's Government what assessment they have made of the impact of (1) reduced pharmacy opening hours, (2) over-capacity pharmacy services, and (3) pharmacists’ staff shortages, on (a) GP, and (b) A&E, services.
To ask His Majesty's Government how many blister medication packs per year are assembled by pharmacies for patients in England.
To ask His Majesty's Government what steps they are taking to ensure that there is an adequate supply of essential services provided by pharmacies, particularly the assembly of blister medication packs to support the safe administration of medicines at ho...
To ask His Majesty's Government, further to the Written Answer by the Minister of State (Department of Health and Social Care) on 21 December 2022 (110613), when they will publish their plan for social care system reform; whether the plan will include (1)...
To ask His Majesty's Government what steps they will take to bring together the different (1) initiatives, (2) white papers, and (3) funding streams, into a clearer plan for social care reform.
To ask His Majesty's Government what public engagement they carried out in 2022 for the NICE Listens programme; what topics NICE Listens will cover in 2023; and whether NICE Listens will include rare diseases in 2023.
To ask His Majesty's Government, further to the England Rare Diseases Action Plan 2022, published on 28 February, what progress has been made in testing new approaches to diagnosing individuals with rare diseases.
To ask His Majesty's Government whether they have made an assessment of the case for publishing an externally facing national strategy for Advanced Therapy Medicinal Products to support patient access.
To ask His Majesty's Government, further to the England Rare Diseases Action Plan 2022, published on 28 February, whether they will publish a list of services where inequitable access has been identified.
To ask His Majesty's Government why they are yet to add any products to the Innovative Medicines Fund.
To ask His Majesty's Government what assessment they have made of the likely number of products that will be eligible for inclusion in the Innovative Medicines Fund in 2022–23 and 2023–24.